Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7317 p371
18 September 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary

Related websites
Draft Mental Health Bill (PDF 1MB)
Draft Mental Health Bill explanatory notes (PDF 500K)


New draft Mental Health Bill published last week

Draft Mental Health Bill

· Sets a new definition of mental disorder to emphasise that it is the effect rather than the underlying cause that matters

· Defines the conditions for compulsion differently, to raise the threshold for the health and safety of patients and to make clear that appropriate treatment must be available for the individual patient

· Proposes hospital assessment as a prerequisite to compulsory treatment in the community

· Allows people to refuse electroconvulsive therapy if they retain mental capacity

· Increases the maximum penalty for people convicted of ill treatment or neglect of patients

Mental health legislation has risen to the top of the Parliamentary agenda again with last week’s publication of a revised Mental Health Bill. The draft has been substantially revised following vigorous opposition to a first draft published two years ago (PJ, 7 December, 2002, p809).

The revised Bill, which proposes the biggest reform of mental health legislation since the 1950s, is so complicated and, in its original form, so controversial that it will be scrutinised by a joint parliamentary committee before being put before Parliament. The pre-legislative scrutiny committee will take evidence from interested parties and recommend further changes to be made to the draft Bill. Specialist pharmacists, for example, are concerned that there is barely any mention of medicines and their use in the latest version.

Health Minister Rosie Winterton said: “We have held extensive discussions with stakeholders since we published a draft Bill for consultation in 2002 and we believe that we now have a Bill that puts a new focus on the individual, allowing compulsory powers to be used in ways that fit with patients’ changing needs. ... People will only be subject to treatment under the Bill if they are at risk of harm to themselves or others. The Bill means that the small minority of people with mental health problems who need to be treated against their wishes, normally for their protection but occasionally to protect the public, will get the right treatment at the right time.”

David Branford, chief pharmacist at Derbyshire Mental Health Services Trust, said: “This is an important piece of legislation for those specialist pharmacists who practise in mental health care. There are many concerns about the way in which psychotropic drugs are used in mental health care and the UK Psychiatric Pharmacy Group has participated in each of the many stages of the consultation process for the replacement of the Mental Health Act 1983. This involved providing evidence to an expert panel, commenting on the expert panel’s report, responding to the Department of Health consultation documents on the reform of the Mental Health Act and then, finally, the 2002 draft Bill.”

The original UKPPG submission made a range of recommendations about the use of medicines in mental health and the need for safeguards. It also made suggestions about how mental health pharmacists could help. Many of the recommendations about the use of medicines in mental health appeared in some form or other in the 2002 draft.

Dr Branford said: “This 2004 draft appears to have put the whole process in reverse. Not only is there no reference to specialist mental health pharmacists there is almost no mention of medicines either. The big question now is whether a code of practice that will be published by the Department of Health before the Bill is debated by Parliament will provide any further guidance about the use of medicines.”

Back to Top


©The Pharmaceutical Journal